APGE FY 2025 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

APGEApogee Therapeutics, Inc.

$4B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$286M

Net Income

-$256M

EPS (Diluted)

$-4.22

Cash Flow

Operating Cash Flow

-$227M

Free Cash Flow

-$233M

Stock-Based Comp.

$46M

Balance Sheet

Total Assets

$937M

Total Liabilities

$33M

Stockholders' Equity

$904M

Cash & Equivalents

$132M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	$0	—
Operating Income	-$286M	-$217M	-31.7%
Net Income	-$256M	-$182M	-40.5%